Kamada KMDA
NASDAQ KMDA
$8.02 +0.13 (+1.65%)
At close: Aug 20, 2026 · 4:00 PM EDT

Kamada (KMDA) Net Margin (2012 - 2026)

Kamada's (KMDA) quarterly Net Margin came in at 14.7% in Q1 2026, down 634.0% YoY from 2.75% in Q1 2025, and up 11.2% on a QoQ basis from 13.22% in Q4 2025.

Kamada (KMDA) Net Margin (2012 - 2026) Analysis & Trends

Kamada (KMDA) has 15 years of Net Margin data on file, last reported at 14.7% in Q1 2026.

  • Quarterly Net Margin fell 634.0% year-over-year to 14.7% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.04% (up 1.0% YoY) and the FY2025 annual result came in at 14.82%, up 723.0% from the prior year.
  • Net Margin improved to 14.7% in Q1 2026, from 13.22% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 21.04% in Q1 2025 to a low of 0.0% in Q1 2023.
  • A 5-year average of 8.32% and a median of 7.15% in 2022 frame the typical range for Net Margin.
  • Annual changes were most pronounced in 2022 — Net Margin jumped 2246 bps — and 2023, when it tumbled 1189 bps.
  • Tracing KMDA's Net Margin over 5 years: stood at 7.15% in 2022, then surged by 92 bps to 13.7% in 2023, then tumbled by 79 bps to 2.85% in 2024, then jumped by 365 bps to 13.22% in 2025, then climbed by 11 bps to 14.7% in 2026.
  • The last three Net Margin figures came in at 14.7% (Q1 2026), 13.22% (Q4 2025), and 15.82% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Haleon 43.83 Bn 42.86 Bn - -
2 Teva Pharmaceutical Industries 42.87 Bn 39.22 Bn 2.15 Bn -13.91%
3 Zoetis 31.41 Bn 29.73 Bn 1.05 Bn 35.09%
4 Takeda Pharmaceutical 28.55 Bn 22.75 Bn 5.10 Bn 9.28%
5 United Therapeutics 22.08 Bn 19.42 Bn 683.80 Mn 42.51%
6 Viatris 18.73 Bn 17.84 Bn 1.46 Bn -3.16%
7 Neurocrine Biosciences 15.44 Bn 15.05 Bn 935.80 Mn 15.06%
8 Elanco Animal Health 11.75 Bn 11.22 Bn 798.00 Mn 3.95%
9 Dr Reddys Laboratories 10.11 Bn 9.94 Bn - -
10 Kamada 462.32 Mn 432.85 Mn 22.47 Mn 16.86%

Historic Data

Download Data
DateValue
Jun 30, 2026 16.86%
Mar 31, 2026 14.70%
Dec 31, 2025 13.22%
Sep 30, 2025 15.82%
Jun 30, 2025 0.00%
Mar 31, 2025 21.04%
Dec 31, 2024 2.85%
Sep 30, 2024 9.66%
Jun 30, 2024 0.00%
Mar 31, 2024 6.66%
Dec 31, 2023 13.70%
Sep 30, 2023 8.50%
Jun 30, 2023 4.84%
Mar 31, 2023 0.00%
Dec 31, 2022 7.15%
Sep 30, 2022 0.00%
Jun 30, 2022 16.73%
Mar 31, 2022 6.51%
Dec 31, 2021 -15.31%
Sep 30, 2021 3.77%